Astellas Pharma Inc.
General ticker "ALPMF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $18.3B (TTM average)
Astellas Pharma Inc. follows the US Stock Market performance with the rate: 37.3%.
Estimated limits based on current volatility of 1.7%: low 12.75$, high 13.16$
Factors to consider:
- Company pays dividends (annually): last record date 2025-09-30, amount 0.26$ (Y1.98%)
Short-term ALPMF quotes
Long-term ALPMF plot
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | ¥1,296,163.00MM | ¥1,518,619.00MM | ¥1,603,672.00MM |
| Operating Expenses | ¥1,076,142.00MM | ¥1,385,590.00MM | ¥1,578,154.00MM |
| Operating Income | ¥220,021.00MM | ¥133,029.00MM | ¥25,518.00MM |
| Non-Operating Income | ¥-63,135.00MM | ¥-668.00MM | ¥-549.00MM |
| Interest Expense | ¥4,949.00MM | ¥8,779.00MM | ¥12,005.00MM |
| R&D Expense | ¥246,010.00MM | ¥276,128.00MM | ¥294,200.00MM |
| Income(Loss) | ¥156,886.00MM | ¥132,361.00MM | ¥24,969.00MM |
| Taxes | ¥0.00MM | ¥0.00MM | ¥7,924.00MM |
| Profit(Loss)* | ¥124,086.00MM | ¥98,714.00MM | ¥17,045.00MM |
| Stockholders Equity | ¥1,460,308.00MM | ¥1,507,954.00MM | ¥1,595,988.00MM |
| Inventory | ¥153,072.00MM | ¥174,386.00MM | ¥248,738.00MM |
| Assets | ¥2,332,395.00MM | ¥2,456,518.00MM | ¥3,569,603.00MM |
| Operating Cash Flow | ¥257,444.00MM | ¥327,767.00MM | ¥172,475.00MM |
| Capital expenditure | ¥76,448.00MM | ¥88,541.00MM | ¥82,497.00MM |
| Investing Cash Flow | ¥-62,413.00MM | ¥-84,500.00MM | ¥-845,802.00MM |
| Financing Cash Flow | ¥-216,298.00MM | ¥-195,623.00MM | ¥614,060.00MM |
| Earnings Per Share** | ¥67.08 | ¥54.24 | ¥9.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.